| INTRODUCTION
Irritable bowel syndrome (IBS) is a chronic stress related functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits. 1 These manifestations substantially impair IBS patient's quality of life. Despite the prevalence and impact of IBS, no evidence-based therapies covering all complaints are currently available. In particular abdominal pain is an unmet clinical need. Of the IBS patients, 35-60% show increased sensitivity of the viscera, described as a decreased threshold of discomfort to colorectal distension compared to healthy controls. 2 This hypersensitivity of the viscera is thought to represent a pathological mechanism explaining abdominal pain in this disorder. Because a clear understanding of the driving forces is currently lacking, few new drugs targeting visceral hypersensitivity are being developed. Recent investigations however, suggested a role for mycobiome dysbiosis. 3 Therefore, we hypothesized that essential oils with known fungicidal activity 4,5 may reverse fungal-induced post stress visceral hypersensitivity in rat, and that such reversal associates with changes of the gut mycobiome.
In a set of small-size clinical trials, peppermint oil was shown to significantly improve abdominal pain complaints in IBS. 6, 7 Menthol, the main component, reduced symptoms of visceral hypersensitivity in mice. 5, 8 Menthol was shown to act via transient receptor potential ion channel melastatin subtype 8 (TRPM8), an ion channel involved in the sensing of cold stimuli by sensory neurons. 8, 9 Activated TRPM8 desensitizes transient receptor potential cation channel subfamily V member 1 (TRPV1), which is involved in IBS and visceral pain perception. 10, 11 Recently, a proprietary combination of essential oils of peppermint (Mentha x piperita L.) and caraway seed (Carum carvi) relieved pain and discomfort in a randomized placebo controlled trial in patients with functional dyspepsia. 12 This formula, known as Menthacarin ® , was also evaluated in a trinitrobenzene sulphonic acid (TNBS)-model of postinflammatory visceral hypersensitivity in rat. Adam et al 13 showed that the combined oils significantly reduced visceral hypersensitivity, whereas the individual oils were not effective. The main component of caraway oil is (+)-carvone. How (+)-carvone contributed to the analgesic effect of menthol was not addressed in this investigation but may relate to its antimicrobial activity. 14 Gut microbiome dysbiosis is a therapeutic target for visceral hypersensitivity, and bacterial dysbiosis was observed in TNBS-and dextran sulfate sodium (DSS)-induced colitis. [15] [16] [17] [18] Recent studies in colitis models and inflammatory bowel disease (IBD) patients showed the relevance of intestinal fungi (mycobiome) for inflammation. [19] [20] [21] [22] [23] Whether the gut mycobiome was also relevant in the post-TNBS visceral hypersensitivity observed by Adam et al is not known, but menthol and (+)-carvone both exhibit antifungal activity. 4, 5 Our own investigations in a rat model of maternal separation not only showed profound changes in gut mycobiome composition of these IBS-like rats, but also reversal of poststress visceral hypersensitivity by antifungal treatment with fluconazole and nystatin. 3 In line with these findings, we observed altered mycobiome composition in IBS patients compared to healthy controls. Consequently, we suggested that manipulation of intestinal fungi can be a treatment option for IBS-related visceral hypersensitivity. 
Both menthol and (+)
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| METHODS

| Animals and ethics statement
Long-Evans rats (Harlan, Horst, The Netherlands) were bred at the animal facility of the Academic Medical Center (AMC, Amsterdam,
The Netherlands). Non-handled and maternally separated rats were housed under open cage conditions and always bred in the same room, but never shared the same cage. All animal procedures were conducted in accordance with the institutional guidelines and approved by the Animal Ethical Committee of the AMC/University of Amsterdam (reference protocol number 100998).
| Maternal separation
Neonatal maternal separation in Long Evans rats predisposes for stress-induced visceral hypersensitivity at adult age. 24 This model mimics early life events shown to be associated with risks of IBS later in life. 25 From postnatal day 2 to 14, dams were separated from the nest for 3 hours daily. During separation, dams were placed in another room and the cage with litter was placed on a heating mat to maintain pup body temperature. Non-handled pups were nursed normally.
Pups were weaned at day 22 and only male rats were used in our investigations.
Key Points
• The gut mycobiome was recently identified as a possible cause for abdominal pain in IBS. We investigated whether a peppermint-and caraway-oil-preparation called Menthacarin ® can modulate mycobiome dependent visceral hypersensitivity in rat.
• The development of visceral hypersensitivity is associated with mycobiome changes. Menthacarin ® reversed visceral hypersensitivity and concomitantly changed the mycobiome composition.
• Abdominal pain in IBS is an unmet clinical need. Our results suggest that Menthacarin ® may be a natural remedy that can be evaluated in a clinical setting.
| Colonic distension protocol and water avoidance
Distensions were performed at the minimum age of 4 months with a latex balloon (Ultracover 8F, International Medical Products BV, Zutphen, The Netherlands) and carried out as described previously. 3, 10, 24 In short, the balloon catheter was inserted under short isoflurane anesthesia and, after 20 minute recovery, colonic distension was achieved by inflation of graded volumes of water (1.0, 1.5, and 2.0 mL). Length and diameter of the balloon during a 2 mL maximum volume distension were 18 and 15 mm respectively. After each 20 second distension period, water was quickly removed and an 80 second resting period was observed. For 1 hour water avoidance (WA) stress at adult age, rats were positioned on a pedestal attached to the bottom of a plexiglass tank that was filled with water within 1 cm of the top of the pedestal.
| Measurement of the visceromotor response to colonic distension and data analysis
Colorectal distension in rat leads to reproducible contractions of abdominal musculature; the so called visceromotor response. We used quantification of these contractions by radio telemetric electromyography to assess visceral pain. Further details on this technique have been published extensively. were evaluated from normalized data sets, which were calculated from the absolute data by setting the 2 mL value of the first distension at 100%. The area under the curve of these relative responses was calculated for individual rats and used for statistical analyses.
| Treatment protocol
Rats were subjected to three colorectal distension protocols during which the visceromotor response was measured; directly before WA (day 0), 1 day after WA (day 1), and 7 days after WA (day 8). 
| Sequencing of fungal ITS amplicons
Barcoded fungal internal transcribed spacer regions (ITS) amplicons were generated using a 2-step PCR approach identical to our previous investigations. 3 In short, fungal ITS 1 regions were first amplified with the following primers: forward 5′-CTTGGTCATTTAGAGGAAGTAA-3′ and reverse 5′-GCTGCGTTCTTCATCGATGC-3′. Next a second set of primers was used to generate fungal ITS-1 fragments that included overhanging adapter sequences for compatibility with Nextera XT tagmentation: next-ITS-BITS-F: TCGTCGGCAGCGTCACCTGCGGARGGATCA and nex-
ITS-B58S3-R GTCTCGTGGGCTCGGGAGATCCRTTGYTRAAAGTT
(adapted from Bokulich & Mills). 27 Reactions were cleaned and dual barcodes (8 bp) and Illumina sequencing adapters were attached using the Nextera XT Index Kit (Illumina, San Diego, CA, USA) according to manufacturer's protocols. Barcoded amplicons were quantified, normalized to the same concentrations, pooled, and gel purified. Pooled amplicons were 250-bp paired-end sequenced using the MiSeq system (Illumina). Raw Illumina fastq files were demultiplexed, quality filtered, and analyzed using modules implemented in the mothur software platform. 28 Unique sequences were taxonomically classified by the RDP-II Naïve Bayesian Classifier 29 using a 60% confidence threshold against the Mothur formated UNITE Database (version no. 7).
30
The raw sequence data generated in this study will be deposited in the European Nucleotide Archive upon acceptance of the manuscript.
| Bacterial 16S sequencing
Analysis of rat microbiome composition was performed by sequencing of the V4 hypervariable region of the 16s rRNA gene on the illumina
MiSeq sequencer. Barcoded DNA fragments spanning the Archaeal and Bacterial V4 hypervariable region were amplified with a standardizing level of template DNA (1 ng) to prevent over-amplification.
These amplicons, generated using adapted primers 533F and 806R, were bidirectionally sequenced using the MiSeq system (Illumina) as described previously. 31 All data extraction, preprocessing, analysis of operational taxonomic units (OTUs) and classifications were performed using modules implemented in the Mothur software platform as in Kelder et al 32 except where noted below. A total of 3 741 564
high-quality sequences were aligned using the "align.seqs" command and the Mothur-compatible Bacterial SILVA SEED database. A total of 8925 unique sequences were retrieved using this pipeline. Sequences were clustered in OTUs using average linkage clustering and a 97%
sequence-identity threshold. Sequences were taxonomically classified by the RDP-II Naive Bayesian Classifier using a 60% confidence threshold. Sequences were normalized to 17 500 sequences per sample (subsampling method).
| Statistical analysis
Statistical analysis was performed using spss for Windows (version Relative abundances of fungal species or bacterial phyla or genera were compared using the Kruskal-Wallis statistic and Dunn's post hoc test. P values <.05 were considered statistically significant in all tests.
| Microbiome and mycobiome visualization
Classical clustering based on Bray-Curtis similarity and the UPGMA algorithm, non-metric multidimensional scaling based on Bray-Curtis similarity, and the Shannon diversity index were performed in the free software platform Past v3.034. Indices concerning the mycobiome were designed from taxonomically classified unique sequences at the species level. Indices concerning the microbiome were designed on OTU abundance. Resulting Shannon indices were compared with 
| RESULTS
| Menthacarin ® reverses stress-induced visceral hypersensitivity in maternally separated rats
Menthacarin ® 's effect on visceral sensitivity was studied in maternally separated and non-handled rats (setup depicted in Figure 1A ).
Results are shown as area under the curve of the relative responses. Thus, non-handled and maternally separated rats showed dissimilar mycobiota prior to treatment, but Menthacarin ® shifted both groups to more similar mycobiomes.
We then sought to corroborate these findings with a β-diversity index, and performed classical clustering using the Bray-Curtis dissimilarity index and the UPGMA algorithm ( Figure 5A ). At 0.48 similarity, the dendrogram showed three separate branches, excluding only one rat. The right-hand branch almost exclusively consisted of normally sensitive rats, i.e. non-handled and maternally separated rats that had been subjected to Menthacarin ® treatment (groups 2 and 4).
The middle branch encompassed most of the hypersensitive rats, i.e.
maternally separated rats that were sampled prior to Menthacarin ® or control treatment and maternally separated rats sampled after
reversal of postwater avoidance (WA) visceral hypersensitivity in maternally separated rats. A, Experimental set up for 7 day post WA Menthacarin ® or control treatment in maternal separation (MS) or non-handled (NH) rats. The visceromotor response (VMR) to colorectal distension was measured at day 0, day 1 and day 8. B, Visceral sensitivity status of maternally separated rats is depicted by area under the curve of the relative response to distension. C, Relative response to distension in non-handled rats. All data are mean ± SD, *P < .05, **P < .01, ****P < .0001, N = 9/group , all in triplicate). Positive controls were fluconazole (fluc) and penicillin-streptomycin (p/s). Data are mean ± SD, *P < .05, **P < .01, ***P < .001, ****P < .00001 (n = 3/test condition) control treatment (groups 3, 5, and 6 respectively). The last branch included six of eight normally sensitive non-handled rats (group 1) that were sampled before Menthacarin ® treatment. Thus, classical clustering confirmed results obtained with co-occurrence spectral analysis.
Finally, our data set was visualized by non-metric multidimensional scaling to show the relation between predisposition (i.e. non-handled or maternally separated), treatment and mycobiome composition.
This ordination technique revealed differential spatial patterns shown in Figure 5B . Non-Menthacarin ® -treated maternal separated and non-handled rats localized to a broad and diffuse spatial area. After Menthacarin ® treatment however, maternally separated and nonhandled rats clustered, suggesting a high level of similarity between rats. In concert, our data suggest that Menthacarin ® treatment is modulating the in vivo mycobiome and these changes associate with a normal response to colorectal distension.
| Maternal separation induced bacterial dysbiosis at multispecies level is not affected by Menthacarin ® treatment
Although our results highlight the importance of intestinal fungi in IBS, a role for intestinal bacteria cannot be excluded. Menthacarin ® showed in vitro bactericidal activity, and bacterial microbiome dysbiosis has been associated with IBS and visceral pain in the maternal separation model. 17, 18 We therefore assessed bacterial microbiome composition and possible effects of Menthacarin ® treatment, by next generation ribosomal DNA sequencing of the bacterial 16S V4 region.
We generated 8925 unique taxonomic units, from which 174 different bacterial genera were taxonomically classified. Bacterial α-diversity was addressed using the relative abundance of unique taxonomic units. Except for a difference between non-handled Menthacarin ® treated rats and non-treated maternally separated rats, we observed no significant differences in α-diversity ( Figure 6A ). Classification of taxa at phylum level showed five dominant phyla.
The relative abundance of none of these phyla differed when comparing pretreatment non-handled and pretreatment maternally separated rats ( Figure 6B ). However, Menthacarin ® treated maternally separated rats had significantly lower Verrucomicrobia compared to all other (i.e. all hypersensitive) maternal separation rats ( Figure 6C , group 4 vs groups 3, 5, and 6). Importantly, we only observed one species, Akkermansia muciniphila, within this phylum. This confirmed earlier reports on the limited intestinal representation of Verrucomicrobia. 37 We also observed changes in the distribution of Bifidobacterium, a genus that belongs to the Actinobacteria phylum. Maternal separated rats showed significantly lower relative abundance compared to non-handled rats and Menthacarin ® treatment induced a significant increase in maternal separated rats ( Figure 6D ). Further analysis on phylum level showed that the relative abundance of Bacteroidetes in Menthacarin ® treated non-handled rats was significantly lower compared to maternal separated rats before and after control. Compared to control treated maternal separated rats, Firmicutes were higher in Menthacarin ® treated non-handled rats (data not shown).
Next, we performed co-occurrence spectral analyses to identify possible clustering of rats based on similarity at genus level ( Figure 6E ).
We identified five main clusters, and most treatment groups were scattered across clusters. In consequence, the clustering pattern did not set apart pretreatment non-handled rats from pretreatment maternally separated rats. Seven of nine Menthacarin ® treated maternally separated rats (group 4) clustered in the middle segment, but this segment also contained four control treated maternally separated rats Finally, we used non-metric multidimensional scaling to visualize the level of similarity between rats ( Figure 7B) . Pretreatment Taken together, this confirmed that bacterial dysbiosis is associated Values range from 0.0 (dark blue for rats who never cluster) to 1.0 (dark red for rats that always cluster). Rat numbers on axes are symmetric and represent individual rats. *P < .05, ** P < .01 and ****P < .0001 (n = 7-9)
F I G U R E 7 Bacterial microbiome analysis using Bray-Curtis dissimilarity index and non-metric multidimensional scaling. A, Hierarchical clustering analysis using Bray-Curtis dissimilarity and UPGMA algorithm. Dotted line and arrow indicate 0.60% similarity. B, Non-metric multidimensional scaling plot based on the Bray-Curtis dissimilarity matrix (Stress: 0.174). Maternal separated rats are represented by red symbols, non-handled rats in black. so it can be envisaged that, despite the absence of major "multispecies level" menthacarin-induced changes in the bacterial microbiome and our earlier evidence on the relevance of gut fungi in the maternal separation model, microbiome changes such as those observed for bifido bacteria may also be relevant.
IBS prevalence rates are higher for women than for men. 1 Yet we choose to evaluate male rats only because the visceromotor response to distension fluctuates with the estrous cycle. 42 Although the different phases can be determined by microscopic evaluation of vaginal secretions, some problems remain to interfere with timing of a strict treatment protocol. Not only is the estrous cycle irregular in an approximate 30% of rats 43 , maternally separated and non-handled rats also respond differently to colorectal distension in the distinct phases of the cycle. 44 Due to our focus on males, we cannot be sure that results on menthacarin-mediated reversal of visceral hypersensitivity and coincided mycobiome changes also apply to female rats. It should also be emphasized that the current investigations showed correlation instead of causal relationship between reversal of visceral hypersensitivity and mycobiome changes. Definitive proof for causality can be obtained by future fecal transfer experiments similar to those performed in our previous study. 3 In addition, we only focused on the gut myco-and microbiome, herewith neglecting other potentially relevant actions of Menthacarin ® . Menthol is one of its active ingredients.
It is known to desensitize, via TRPM8, the TRPV1 receptor which is relevant in visceral nociception in IBS and the maternal separation model. 10, 11 Menthol is also a smooth muscle calcium channel antagonists that causes (similar to caraway) 45 muscle relaxation. This may be beneficial because dysmotility in IBS was shown to correlate with abdominal pain. Furthermore, menthol is known to have kappa opioid agonistic and serotonin receptor antagonistic activity which may both lead to analgesia. 6 Because we did not address these mechanisms, we cannot judge their relative weight for the observed reversal of visceral hypersensitivity. After 24 hours treatment in a recent clinical trial with peppermint oil, abdominal pain scores of the treatment group showed a significant 21% reduction from baseline vs 9% with placebo. At 28 days however, these numbers increased to 41% with peppermint oil vs 22% with placebo. 46 Possibly, results at the early time point reflected direct TRP channel and opioid receptor mediated effects only, whereas the doubled response at 28 days included more time demanding changes of the gut mycobiome. Unfortunately, the mycobiome nor any of the other possible mechanisms were addressed in this patient trial and the peppermint formulation lacked caraway oil, which was present in our investigations in rat. Irrespective, it can be argued that the possibility of synergistic analgesic activities make Menthacarin ® an ideal candidate for IBS therapy. In the randomized placebo-controlled clinical trial in patients with functional dyspepsia that was mentioned earlier, the same peppermint-and caraway-oilpreparation was well-tolerated. 12 Finally, future use of this preparation would also satisfy patient preference for biological therapy. 47, 48 We previously suggested that gut mycobiome modulation can be an effective treatment for abdominal pain in IBS. 
